Position
Squarepoint Ops LLC in Ocular Therapeutix, Inc
Back to the book · All holders of OCUL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.62M$12.14 → $8.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 440.4K | $5.35M | — | — | — | 0.0% |
| Q1 2026 | 980.8K | $8.31M | $8.47 | −$1.62M | $4.58M | 0.0% |